It is hard to see any negatives from the current share price, their is only growth with a company like this expanding into new markets. Cash in bank so expansion is already funded.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025